Kush Parmar, Director at Entrada Therapeutics, Inc. (TRDA), sold 155,255 shares at $7.00 ($1.1M) on 2026-08-06, disclosed to the SEC on 2026-08-10.
Open-market sale of $1.1M TRDA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.00 | 10,494 | $73K | 6.8% |
| 2 | $6.85 | 52,317 | $358K | 33.2% |
| 3 | $7.00 | 92,444 | $647K | 60.0% |
| Total | $6.95 avg | 155,255 | $1.1M | 100% |
| Filing → |
| TRDA | SELL | 2025-07-11 | $405K | — | Filing → |
| TRDA | SELL | 2025-07-01 | $1.6M | — | Filing → |
| SKYE | BUY | 2024-03-15 | $4.5M | — | Filing → |